Ligand validation:4C9H

CDL: CARDIOLIPIN

CDL is a Ligand Of Interest in 4C9H designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4C9H_CDL_A_801	22%	37%	0.189	0.91	1.2	1.37	4	5	4	0	43%	0.43
4C9H_CDL_B_801	20%	38%	0.21	0.912	1.18	1.31	4	4	3	0	44%	0.44
4C9H_CDL_A_802	16%	37%	0.221	0.893	1.3	1.23	4	5	1	0	44%	0.44
4C9H_CDL_A_800	11%	46%	0.246	0.895	0.97	1.15	1	2	0	0	26%	0.26
4C9H_CDL_B_800	10%	47%	0.241	0.881	0.98	1.1	1	2	1	0	27%	0.27
4C9H_CDL_B_802	10%	35%	0.268	0.869	1.34	1.34	4	5	1	0	45%	0.45
4C9G_CDL_A_802	18%	34%	0.19	0.889	1.36	1.35	4	4	4	0	37%	0.37
5Y5S_CDL_M_415	41%	36%	0.128	0.953	1.32	1.27	3	3	1	0	39%	0.39
2GNU_CDL_M_1309	38%	24%	0.122	0.984	1.77	1.5	3	3	0	0	10%	10
3ZDQ_CDL_A_1721	37%	64%	0.215	0.943	0.72	0.65	4	4	0	1	84%	0.42
6JY3_CDL_B_301	33%	27%	0.163	0.908	1.53	1.57	5	14	0	0	64%	0.64
7COH_CDL_A_521	33%	72%	0.212	0.901	0.46	0.6	-	2	6	0	94%	0.94

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.